Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?

Overview of attention for article published in BMC Cancer, October 2015

Altmetric Badge

Citations

So far, Dimensions has found 4 publications that cite this research output.

Article in International Journal of Clinical Oncology (November 2023)

Article in Molecular Genetics & Genomic Medicine (June 2022)

Article in International Journal of Clinical Oncology (December 2019)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.